European Society of Toxicology In Vitro > News > Welcoming Luiz Ladeira to the ESTIV Board!
26 October 2024

Welcoming Luiz Ladeira to the ESTIV Board!

We are excited to announce that Dr. Luiz Ladeira has joined the ESTIV Board! Luiz brings exceptional expertise in physiological maps and AOP research, as well as a strong commitment to advancing in vitro and in silico toxicology. We look forward to his contributions as we continue to drive progress in toxicological research and support our vibrant ESTIV community. Welcome aboard, Luiz!

Dr. Luiz Ladeira

Short Bio:
Luiz Ladeira is a postdoctoral researcher at the Biomechanics Research Unit, GIGA Institute – Molecular and Computational Biology, University of Liège, Belgium. He is a trained nutritionist and holds an MSc and PhD in Cell and Structural Biology from the Federal University of Viçosa (UFV), Brazil. His recent research, mostly in the ONTOX project (https://ontox-project.eu/), is focused on supporting NAMs development by setting the physiological grounds for Adverse Outcome Pathways building and refinement, computational modeling rationale, and ontology maps construction. Luiz volunteers at the VPH Institute (https://www.vph-institute.org/) and the Avicenna Alliance (https://www.avicenna-alliance.com/), advocating for in silico methods in healthcare and research. Luiz recently joined the ESTIV board to continue promoting alternative methods in toxicology and help shape the next generation of toxicologists through the ESTIV Early Career Network.

Related content

The ESTIV 2026 Special Issue is open for submissions

Toxicology in Vitro is now accepting manuscripts for the Special Issue arising from the ESTIV 2026 Congress held in Maastricht. The collection takes its direction from the congress theme — “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs” — and is open until 31 December 2026.

ESTIV: ERA4NAMs Survey – request for contribution

The ERA4NAMs Working Group on Education and Training is conducting a mapping exercise to identify existing training activities, educational resources, and capacity-building initiatives related to New Approach Methodologies (NAMs) across Europe and beyond.

The inaugural Liebsch & Spielmann Award presented at the ESTIV 2026 Congress

The European Society of Toxicology In Vitro (ESTIV) is proud to announce the recipients of the inaugural Liebsch & Spielmann Award for Contributions to the Validation of Alternative Methods.

Silver Sponsor

Communication partners

Memorandum of Understanding